Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.72186 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.72528 | 32 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.68986 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.71267 | 34 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.64935 | 31 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.73175 | 29 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.76873 | 32 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.88224 | 39 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.68964 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.71821 | 32 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.71079 | 32 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.71316 | 33 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.72303 | 32 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.712 | 32 |